Ayala Pharmaceuticals, Inc. (ADXS)

Ayala Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022
Period Ending	Mar 28, 2025	Dec 31, 2023	Dec 31, 2022
Market Capitalization	2	8	-
Enterprise Value	6	7	-
Last Close Price	0.04	0.67	-
PS Ratio	20.84	610.40	-
PB Ratio	-0.32	-0.32	-
EV/Sales Ratio	559.86	559.86	-
Debt / Equity Ratio	-0.34	-0.34	-1.59
Asset Turnover	0.00	0.00	-
Quick Ratio	0.20	0.20	0.43
Current Ratio	0.30	0.30	0.51
Return on Assets (ROA)	-181.05%	-181.05%	-
Earnings Yield	-2166.87%	-605.81%	-
Buyback Yield / Dilution	-107.90%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.